BioMimetic Therapeutics Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BioMimetic Therapeutics Inc. - overview

Established

1999

Location

Franklin, TN, US

Primary Industry

Pharmaceuticals

About

Founded in 1999 and based in Tennessee, US, BioMimetic Therapeutics Inc. is a biotechnology company that focuses on the development of protein-based products for the treatment of musculoskeletal and orthopedic disorders including bone, cartilage, tendon and ligament injuries.


Current Investors

Burrill & Company, InterWest Partners, Presidio Partners

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.biomimetics.com

Verticals

HealthTech

Company Stage

Mature

Total Amount Raised

Subscriber access only

BioMimetic Therapeutics Inc. - financials

Fiscal Year EndedDec 31, 2006Dec 31, 2007Dec 31, 2008Dec 31, 2009Dec 31, 2010Dec 31, 2011
Revenue (USD)4,133,9397,030,2843,148,384---
% Revenue Growth (YoY)-70.1%(55.2%)---
EBITDA (USD)(16,270,215)(24,956,502)(32,665,036)---
Operating Income (USD)(19,228,410)(28,320,016)(36,751,676)---
Operating Margin(465.1%)(402.8%)(1167.3%)---
% EBITDA Margin(393.6%)(355.0%)(1037.5%)---
NET Income (USD)(17,064,064)(24,581,752)(8,004,997)---
% Net Margin(412.8%)(349.7%)(254.3%)---

BioMimetic Therapeutics Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

BioMimetic Therapeutics Inc. - key contacts

NamePositionStart DateEnd DateVcardBio 
Member Board of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.